{"id":23643,"date":"2015-12-25T12:22:33","date_gmt":"2015-12-25T11:22:33","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=23643"},"modified":"2015-12-26T10:18:22","modified_gmt":"2015-12-26T09:18:22","slug":"spesa-farmaci-dati-aifa-nei-primi-otto-mesi-sfondamento-totale-al-17","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/spesa-farmaci-dati-aifa-nei-primi-otto-mesi-sfondamento-totale-al-17\/","title":{"rendered":"Drug expenditure, Aifa data: total breakthrough at 17% in the first eight months"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" src=\"http:\/\/www.lospiffero.com\/images\/galleries\/Aifa.jpg\" alt=\"\" width=\"267\" height=\"218\" \/>Put together territorial pharmaceutical and hospital assistance<\/strong>, in the first eight months of 2015 it breached the ceiling on NHS spending on medicines by more than 17%. This is the balance that comes from the latest report with which AIFA monitors the prescriptions and consumption of drugs in the Regions, relating to the January-August period: the approved pharmaceutical expenditure, i.e. that which passes through local pharmacies, reaches 5.7 billion euros and remains practically stable compared to the same period last year (-0.7%); expenditure for direct distribution\/dpc, which passes through the Local Health Authorities, instead grows by almost 30% and reaches 2.7 billion euros; lastly, hospital pharmaceutical expenditure exceeds 4 billion euros.<\/p>\n<p><strong>As already in past years, the main weight<\/strong> of the breakthrough recorded by AIFA must be attributed precisely to the hospital, which in the first eight months comes to weigh on the overall health expenditure for 5.2% when it should not exceed 3.5%. On the other hand, the overrun of the territorial (more direct agreement\/dpc) is much more contained, which is worth 12.3% of NHS spending when the ceiling is 11.35%. Once again, in essence, the pharmaceutical expenditure that passes through the territory shows that it is well governed and monitored, while that of hospitals continues to overwhelm embankments and roofs.<\/p>\n<p>(<a href=\"https:\/\/www.federfarma.it\/Edicola\/FiloDiretto\/Filodiretto\/dicembre2015\/24-12-2015-00-21-26.aspx\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">24\/12\/2015 \u2013 AS \u2013 Federfarma<\/span><\/a>)<\/p>\n<h1 id=\"page-title\"><span style=\"color: #ff0000;\">Monitoring of Regional Pharmaceutical Expenditure (January \/ August 2015) (23\/12\/2015)<\/span><\/h1>\n<div id=\"content\" class=\"section region\">\n<div id=\"node-19004\" class=\"node node-general\">\n<div class=\"node-inner\">\n<div class=\"node-content\">\n<div class=\"field field-type-text field-field-occhiello\">\n<div class=\"field-items\">\n<div class=\"field-item odd\">\n<p><a href=\"http:\/\/www.agenziafarmaco.gov.it\/it\/content\/monitoraggio-della-spesa-farmaceutica-regionale-gennaio-agosto-2015-23122015\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">AIFA notice \u2013 23\/12\/2015<\/span><\/a><\/p>\n<p><img decoding=\"async\" class=\"alignright\" src=\"http:\/\/www.hmct.it\/wp-content\/uploads\/esenzioneticket.jpg\" alt=\"\" \/>AIFA fulfillment pursuant to Law 222\/2007, conducted on the basis of the OsMed agreed expenditure data and the DCRs acquired by AGENAS on 28 October 2015 (prot. n\u00b0 0108113- 28\/10\/2015-AIFA-AIFA-A ) as well as data certified by the Regions and by the NSIS on the traceability date of 31 August 2015 (DM 15 July 2004) - acquired by AIFA on 11 November 2015 (prot. n\u00b0 0113847-11\/11\/2015-AIFA-AIFA -A) and direct distribution (DM 31 July 2007) acquired by AIFA on 20 November 2015 (prot. n\u00b0 0118090-20\/11\/2015-AIFA-AIFA-A).<\/p>\n<p><em>Attached is the extract from <span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"http:\/\/www.agenziafarmaco.gov.it\/sites\/default\/files\/estratto_Monitoraggio_Spesa_Regionale_gen-ago_2015.pdf\" target=\"_blank\" rel=\"noopener\">Monitoring of Regional Pharmaceutical Expenditure<\/a><\/span> (January \/ August 2015)<\/em><\/p>\n<p>Related news:\u00a0<a href=\"https:\/\/www.federfarma.it\/Edicola\/Ultime-notizie\/23-12-2015-06-29-10.aspx\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Direct vs dpc, Sifo reopens disputes with an investigation to be understood<\/span><\/a><\/p>\n<p class=\"Title\"><a href=\"https:\/\/www.federfarma.it\/Edicola\/FiloDiretto\/Filodiretto\/dicembre2015\/23-12-2015-06-14-09.aspx\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Pharmacy market 2015, from Ims Health encouraging data<\/span><\/a><\/p>\n<p class=\"Title\"><a href=\"http:\/\/www.romait.it\/articoli\/20011\/farmaci-distribuiti-dalle-aziende-sanitarie-cosi-si-risparmia\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Medicines distributed by Health Authorities: this is how you save<\/span><\/a>. A SIFO study on Ferrara and Rome<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Messe assieme assistenza farmaceutica territoriale e ospedaliera, nei primi otto mesi del 2015 sfonda per pi\u00f9 del 17% il tetto sulla spesa del Ssn per i medicinali. E\u2019 il bilancio che arriva dall\u2019ultimo report con cui l\u2019Aifa monitora prescrizioni e consumi dei farmaci nelle Regioni, relativo al periodo gennaio-agosto: la spesa farmaceutica convenzionata, cio\u00e8 quella &hellip;<\/p>","protected":false},"author":4,"featured_media":19759,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[49,26,79],"class_list":["post-23643","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-aifa","tag-spesa-farmaceutica","tag-ssn"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/23643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=23643"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/23643\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/19759"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=23643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=23643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=23643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}